About AxioMx
AxioMx is a company based in Branford (United States) founded in 2012 by Christopher McLeod was acquired by Abcam in November 2015.. AxioMx has raised $4.11 million across 8 funding rounds from investors including Abcam, NIH and HHS. AxioMx operates in a competitive market with competitors including Somalogic, Nautilus Biotechnology, Amunix, Biognosys and Elektrofi, among others.
- Headquarter Branford, United States
- Founders Christopher McLeod
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AxioMx
AxioMx has successfully raised a total of $4.11M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $216 thousand completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Grant — $216,000
-
First Round
First Round
(06 Nov 2012)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Grant - AxioMx | Valuation |
investors |
|
| Mar, 2015 | Amount | Grant - AxioMx | Valuation |
investors |
|
| Feb, 2015 | Amount | Grant - AxioMx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AxioMx
AxioMx has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Abcam, NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Founded Year | Domain | Location | |
|
VC firm investing in seed & early stage companies in the US
|
Founded Year | Domain | Location | |
|
Private investments are made in early and later-stage businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AxioMx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AxioMx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Axiomx Comparisons
Competitors of AxioMx
AxioMx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Nautilus Biotechnology, Amunix, Biognosys and Elektrofi, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| domain | founded_year | HQ Location |
Digital platform transforming the delivery of biologic medicines
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about AxioMx
When was AxioMx founded?
AxioMx was founded in 2012.
Where is AxioMx located?
AxioMx is headquartered in Branford, United States. It is registered at Branford, Connecticut, United States.
Who is the current CEO of AxioMx?
Christopher McLeod is the current CEO of AxioMx. They have also founded this company.
Is AxioMx a funded company?
AxioMx is a funded company, having raised a total of $4.11M across 8 funding rounds to date. The company's 1st funding round was a Grant of $220.32K, raised on Nov 06, 2012.
What does AxioMx do?
AxioMx was founded in 2012 in Branford, United States, within the biotechnology sector. A platform for recombinant antibody discovery and development services is maintained, featuring phage display libraries, screening, and affinity maturation techniques to shorten antibody development timelines. Services encompass recombinant antibody development, optimization, antigen design, and project planning. The company was acquired by Abcam in 2015.
Who are the top competitors of AxioMx?
AxioMx's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.
Who are AxioMx's investors?
AxioMx has 6 investors. Key investors include Abcam, NIH, HHS, Elm Street Ventures, and Connecticut Innovations.